Market Overview
The Companion Animal Diagnostics Market covers diagnostic solutions including clinical chemistry analyzers, immunoassays, molecular diagnostics, hematology systems, and urinalysis equipment used in veterinary clinical settings and reference laboratories. These diagnostics help veterinarians detect, monitor, and manage diseases ranging from infectious conditions to chronic illnesses in companion animals.
- •Market valued at $3.68 billion in 2025 with 7.8% CAGR projected through 2031
- •Includes instruments, consumables, and services for dogs, cats, horses, and other companion animals
- •Part of the broader veterinary diagnostics sector approaching $5.36 billion by 2030
Growth Drivers
The humanization trend, where pets are increasingly treated as family members, has significantly increased spending on their healthcare. Pet owners now expect advanced diagnostic capabilities comparable to human medicine, while rising pet insurance coverage makes expensive testing more accessible. Additionally, growing companion animal populations globally and increased prevalence of chronic and zoonotic diseases are expanding the addressable market.
- •Humanization of pets driving premium veterinary care spending and demand for advanced diagnostics
- •Growing pet insurance adoption reducing out-of-pocket costs and encouraging comprehensive testing
- •Rising incidence of companion animal diseases and zoonotic concerns increasing preventive care
Segmentation and Regional Analysis
The market segments by animal type (dogs, cats, horses, and others), product type (clinical chemistry, immunodiagnostics, molecular diagnostics, hematology, and urinalysis), and geography. North America currently leads the market due to high pet ownership rates, advanced veterinary infrastructure, and favorable pet insurance penetration. Asia-Pacific is emerging as the fastest-growing region, fueled by rising disposable incomes and expanding companion animal populations.
- •Product segments include clinical chemistry, immunoassays, molecular diagnostics, and point-of-care testing
- •North America dominates market share with advanced veterinary healthcare infrastructure
- •Asia-Pacific shows fastest growth potential driven by increasing pet ownership and veterinary spending
Trends and Outlook
What are the recent trends and outlook?
Technological innovation is reshaping the market with point-of-care testing becoming standard in veterinary practices, reducing turnaround times and improving clinical outcomes. Molecular diagnostics and genomic testing are gaining traction for breed-specific disease screening and precision veterinary medicine. The integration of artificial intelligence for image analysis and data interpretation, along with growth in at-home testing kits, represents the next frontier for market expansion.
- •Point-of-care diagnostics accelerating adoption through rapid results and practice workflow efficiency
- •Molecular diagnostics and genomics enabling breed-specific health management and personalized medicine
- •AI-powered diagnostic tools and telemedicine integration creating new market opportunities
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.